The following is offered to aid investors relating to today's trade:
The stock traded between an intraday low of 32.0c and seventeen-day high of 36.50c. The price range has expanded in the last two days (from 2.50c two days ago to 4.50c today) which, accompanied by a price rise.
Moving Average Price (MAP): The price to 200-day MAP ratio is 0.4, a bearish indicator. In the past 200 days this ratio has been under 0.4 63 times suggesting further downside. The 50-day MAP of 33.66c is lower than the 200-day MAP of 90.18c, a bearish indicator. The 200-day MAP has decreased to 90.18c. A decrease is another bearish indicator. In the last three months the number of falls outnumbered rises 32:25 or 1.28:1.
Relativities: Today its percentile rank in the Australian market was 95. In the Australian market of 1,793 stocks, the stock has a 6-month relative strength of 22 indicating it is trailing 78.0% of the market.
Volume: There were 8,899,665 shares worth $3 million traded.
Volume Weighted Price (VWP): The price is at a premium of 28.2% to the 1-month volume weighted average price of 28.48c. In the past year the premium has been greater than 28.2% just once, suggesting a topish level and cautious buying at the current price.
Beta is 2.8.
- Forums
- ASX - By Stock
- LYC
- re:
re:
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.60 |
Change
-0.150(1.94%) |
Mkt cap ! $7.103B |
Open | High | Low | Value | Volume |
$7.64 | $7.69 | $7.56 | $20.43M | 2.681M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 29813 | $7.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.60 | 121468 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 29813 | 7.590 |
1 | 12970 | 7.560 |
6 | 27984 | 7.550 |
3 | 20970 | 7.540 |
2 | 32806 | 7.530 |
Price($) | Vol. | No. |
---|---|---|
7.600 | 121468 | 3 |
7.610 | 569 | 1 |
7.620 | 13173 | 4 |
7.630 | 10144 | 2 |
7.640 | 10159 | 2 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online